Purchase this article with an account.
H E Kaufman; Herpetic keratitis. Proctor Lecture.. Invest. Ophthalmol. Vis. Sci. 1978;17(10):941-957.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Although much needs to be learned about the serious clinical problem of herpes infection of the cornea, we have come a long way. We now have effective topical antiviral drugs. We have animal models which, with a high degree of reliability, clearly predict the effect to be expected clinically in man, as well as the toxicity. We have systemically active drugs and the potential of getting highly active, potent, completely selective drugs, with the possibility that perhaps the source of viral reinfection can be eradicated. The biology of recurrent herpes and stromal disease is gradually being understood, and this understanding may result in new and better therapy of this devastating clinical disease.
This PDF is available to Subscribers Only